English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
 
 
DownloadE-Mail
  Circulating CD22+CD20-CD19+ cells at baseline may predict the clinical response to rituximab in patients with active RA.

Owczarczyk, K., Passon, D., Roehrs, T., Jung, N., Taubert, D., Valet, G., et al. (2007). Circulating CD22+CD20-CD19+ cells at baseline may predict the clinical response to rituximab in patients with active RA. Zeitschrift fur Rheumatologie, 66(Suppl. Suppl. 1), 40-40.

Item is

Basic

show hide
Genre: Journal Article
Alternative Title : Z. Rheumatol.

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Owczarczyk, K., Author
Passon, D., Author
Roehrs, T., Author
Jung, N., Author
Taubert, D., Author
Valet, G.1, Author           
Rubbert, A., Author
Affiliations:
1Former Research Groups, Max Planck Institute of Biochemistry, Max Planck Society, ou_1565145              

Content

show

Details

show
hide
Language(s): eng - English
 Dates: 2007-09
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Identifiers: eDoc: 328417
ISI: 000249687900112
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Zeitschrift fur Rheumatologie
  Alternative Title : Z. Rheumatol.
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 66 (Suppl. Suppl. 1) Sequence Number: - Start / End Page: 40 - 40 Identifier: ISSN: 0340-1855